When should antiretroviral therapy for HIV be started?

Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren

doi:10.1136/bmj.39064.406389.94

When should antiretroviral therapy for HIV be started?

Andrew N Phillips, Brian G Gazzard, Nathan Clumeck, Marcelo H Losso, Jens D Lundgren

59 Citationer (Scopus)

Abstract

Udgivelsesdato: 2007/1/13

Originalsprog	Engelsk
Tidsskrift	B M J
Vol/bind	334
Udgave nummer	7584
Sider (fra-til)	76-78
Antal sider	3
ISSN	0959-8146
DOI	https://doi.org/10.1136/bmj.39064.406389.94
Status	Udgivet - 2007

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1136/bmj.39064.406389.94

http://www.bmj.com/cgi/content/full/334/7584/76#bibl

Citationsformater

@article{4958a5e020ec11ddbc23000ea68e967b,

title = "When should antiretroviral therapy for HIV be started?",

abstract = "Udgivelsesdato: 2007/1/13",

keywords = "Acquired Immunodeficiency Syndrome, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections, Humans, Risk Factors",

author = "Phillips, {Andrew N} and Gazzard, {Brian G} and Nathan Clumeck and Losso, {Marcelo H} and Lundgren, {Jens D}",

year = "2007",

doi = "10.1136/bmj.39064.406389.94",

language = "English",

volume = "334",

pages = "76--78",

journal = "The BMJ",

issn = "0959-8146",